Us Fda Approval
- All
- News
- Videos
-
Lenacapavir: The 'Breakthrough Of The Year' Drug For HIV Care
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication.
-
"Tea Is Healthy": India's Favourite Beverage Gets US FDA's Approval
The FDA announced a final rule updating the "healthy" nutrient content claim to help consumers identify foods that align with dietary recommendations.
-
Apple Receives US FDA Approval to Enable AirPods Pro 2 Hearing Aids Feature
AirPods Pro (2nd Generation) users will be able to use the company's truly wireless stereo (TWS) headset as a hearing aid in the future, as Apple has now received approval from the US Food and Drug Administration (FDA) to enable the feature. An update will also bring support for a new hearing test, which will generate an audio profile for the heari...
-
Elon Musk's Neuralink Gets Go Ahead For Brain Chip Implant In 2nd Patient: Report
The US health regulator has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after it proposed to fix a problem that occurred in its first patient, the Wall Street Journal reported on Monday.
-
US Approves First Drug For People With Severe Form Of Fatty Liver Disease
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
-
Miracle Drug That Could Extend Dogs' Lives Inches Closer to Approval
A medication with the potential to prolong the lifespans of large dogs and contribute to their overall health in aging is nearing its market debut.
-
Elon Musk's Neuralink Receives Approval to Start Brain Implant Human Trial for Paralysis Patients
Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.
-
US Approves First Pill For Postpartum Depression
The FDA said zuranolone is "the first oral medication indicated to treat postpartum depression (PPD) in adults."
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
Apple Working on Hearing Health Monitoring Features for AirPods, May Be Ready in Two Years: Mark Gurman
Apple is reportedly planning to bring health features to the AirPods product line, but not before 2025. According to Bloomberg;s Mark Gurman, the tech giant is likely to add hearing-based health features to the AirPods including, “the ability to get hearing data of some sort," within the next two years.
-
Alembic Pharma Gets Regulator's Approval To Market Antidepressant Drug In US
Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration to market Brexpiprazole tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
-
Neuralink Expected to Begin Human Clinical Trials in Six Months, Elon Musk Says
Neuralink is expected to begin human trials in six months, Elon Musk said on Wednesday. The brain chip interface is running behind schedule, and is said to have repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials. Over a year ago, Neuralink demonstrated its technology on a monkey with a ...
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Lenacapavir: The 'Breakthrough Of The Year' Drug For HIV Care
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication.
-
"Tea Is Healthy": India's Favourite Beverage Gets US FDA's Approval
The FDA announced a final rule updating the "healthy" nutrient content claim to help consumers identify foods that align with dietary recommendations.
-
Apple Receives US FDA Approval to Enable AirPods Pro 2 Hearing Aids Feature
AirPods Pro (2nd Generation) users will be able to use the company's truly wireless stereo (TWS) headset as a hearing aid in the future, as Apple has now received approval from the US Food and Drug Administration (FDA) to enable the feature. An update will also bring support for a new hearing test, which will generate an audio profile for the heari...
-
Elon Musk's Neuralink Gets Go Ahead For Brain Chip Implant In 2nd Patient: Report
The US health regulator has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after it proposed to fix a problem that occurred in its first patient, the Wall Street Journal reported on Monday.
-
US Approves First Drug For People With Severe Form Of Fatty Liver Disease
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
-
Miracle Drug That Could Extend Dogs' Lives Inches Closer to Approval
A medication with the potential to prolong the lifespans of large dogs and contribute to their overall health in aging is nearing its market debut.
-
Elon Musk's Neuralink Receives Approval to Start Brain Implant Human Trial for Paralysis Patients
Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.
-
US Approves First Pill For Postpartum Depression
The FDA said zuranolone is "the first oral medication indicated to treat postpartum depression (PPD) in adults."
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
Apple Working on Hearing Health Monitoring Features for AirPods, May Be Ready in Two Years: Mark Gurman
Apple is reportedly planning to bring health features to the AirPods product line, but not before 2025. According to Bloomberg;s Mark Gurman, the tech giant is likely to add hearing-based health features to the AirPods including, “the ability to get hearing data of some sort," within the next two years.
-
Alembic Pharma Gets Regulator's Approval To Market Antidepressant Drug In US
Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration to market Brexpiprazole tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
-
Neuralink Expected to Begin Human Clinical Trials in Six Months, Elon Musk Says
Neuralink is expected to begin human trials in six months, Elon Musk said on Wednesday. The brain chip interface is running behind schedule, and is said to have repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials. Over a year ago, Neuralink demonstrated its technology on a monkey with a ...
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
